(19)
(11) EP 4 515 245 A1

(12)

(43) Date of publication:
05.03.2025 Bulletin 2025/10

(21) Application number: 23723436.4

(22) Date of filing: 26.04.2023
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6893; G01N 2800/347; G01N 2800/042
(86) International application number:
PCT/EP2023/060911
(87) International publication number:
WO 2023/208993 (02.11.2023 Gazette 2023/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 29.04.2022 GB 202206257

(71) Applicant: Randox Laboratories Ltd
Crumlin, Antrim BT29 4QY (GB)

(72) Inventors:
  • RUDDOCK, Mark
    Crumlin Antrim BT294QY (GB)
  • JOANNE, Watt
    Crumlin Antrim BT294QY (GB)
  • FITZGERALD, Peter
    Crumlin Antrim BT294QY (GB)
  • LAMONT, John
    Crumlin Antrim BT294QY (GB)

   


(54) BIOMARKERS OF DIABETIC NEPHROPATHY